Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura
Status:
Unknown status
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
The following study is being conducted to explore the safety and effectiveness of a new
chemical entity called NXN-188 in subjects with a history of migraine with aura. In this
study subjects will treat two attacks of migraine with aura during the aura phase - once with
placebo and once with NXN-188.